首页> 外文OA文献 >Depleted Tumor Suppressor miR-107 in Plasma Relates to Tumor Progression and Is a Novel Therapeutic Target in Pancreatic Cancer

【2h】

Depleted Tumor Suppressor miR-107 in Plasma Relates to Tumor Progression and Is a Novel Therapeutic Target in Pancreatic Cancer

机译：血浆中耗尽的肿瘤抑制器miR-107涉及肿瘤进展，并且是胰腺癌中的新疗法靶标

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Taisuke Imamura; Shuhei Komatsu; Daisuke Ichikawa; Wataru Okajima; Takuma Ohashi; Jun Kiuchi; Keiji Nishibeppu; Hisashi Ikoma; Hiroki Taniguchi; Eigo Otsuji;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Depleted Tumor Suppressor miR-655 in Plasma Contributes to Poor Outcomes and Is a Novel Therapeutic Target in Esophageal Squamous Cell Carcinoma [J] . Kiuchi Jun, Komatsu Shuhei, Ichikawa Daisuke, Journal of the American College of Surgeons . 2017,第4Suppla1期

机译：血浆中耗尽的肿瘤抑制miR-655有助于差的结果，并且是食管鳞状细胞癌中的新治疗靶标
2. Depleted Tumor Suppressor miR-655 in Plasma Contributes to Poor Outcomes and Is a Novel Therapeutic Target in Esophageal Squamous Cell Carcinoma [J] . Kiuchi Jun, Komatsu Shuhei, Ichikawa Daisuke, Journal of the American College of Surgeons . 2017,第4Suppla1期

机译：血浆中耗尽的肿瘤抑制miR-655有助于差的结果，并且是食管鳞状细胞癌中的新治疗靶标
3. Context dependence of checkpoint kinase 1 as a therapeutic target for pancreatic cancers deficient in the BRCA2 tumor suppressor. [J] . Hattori H, Skoulidis F, Russell P, Molecular cancer therapeutics . 2011,第4期

机译：背景检查点激酶1作为BRCA2肿瘤抑制因子缺乏的胰腺癌的治疗靶点的背景依赖性。
4. Hypoxia in tumors: molecular targets foranti-cancer therapeutics [C] . Kaye J. Williams, achel L. Cowen, Louisa M. Brown, International Symposium on Regulation of Enzyme Activity and Synthesis in Normal and Neoplastic Tissues . 2004

机译：肿瘤缺氧：分子靶向癌症治疗剂
5. Cadherin-11mediation of tumor progression and invasion in poor prognosis cancers: A viable therapeutic target. [D] . Guidry Auvil, Jaime Marie. 2009

机译：在不良预后的癌症中，Cadherin-11介导的肿瘤进展和侵袭：可行的治疗靶点。
6. Depleted tumor suppressor miR-107 in plasma relates to tumor progression and is a novel therapeutic target in pancreatic cancer [O] . Taisuke Imamura, Shuhei Komatsu, Daisuke Ichikawa, -1

机译：血浆中耗尽的抑癌基因miR-107与肿瘤进展有关是胰腺癌的新型治疗靶标
7. Context Dependence of Checkpoint Kinase 1 as a Therapeutic Target for Pancreatic Cancers Deficient in the BRCA2 Tumor Suppressor [O] . Hiroyoshi Hattori, Ferdinandos Skoulidis, Paul Russell, 2011

机译：检查点激酶1作为BRCA2肿瘤抑制缺乏胰腺癌的治疗靶标的上下文依赖性

Depleted Tumor Suppressor miR-107 in Plasma Relates to Tumor Progression and Is a Novel Therapeutic Target in Pancreatic Cancer

著录项

引文网络

相似文献

相关主题

期刊订阅